Biological activity of 5-aminolevulinic acid and its methyl ester after storage under different conditions.

5-Aminolevulinic acid (ALA) is a natural precursor of protoporphyrin IX (PpIX) and heme in cells. Photodynamic therapy (PDT) utilizes a metabolic imbalance in cancer cells, leading to increased PpIX generation from exogenous ALA. Due to chemical instability of ALA in therapeutic concentrations at pH values larger than 5.0 and at high temperatures, it looses its activity by spontaneous dimerization to 2,5-dicarboxyethyl-3,6-dihydropyrazine (DHPY). ALA esters are now supplementing ALA in PDT, but little is known about their stability. We have studied the stability of ALA and its methyl ester (MAL) stored under different conditions (temperatures, pH values) by measuring their ability to generate PpIX. 100mM solutions of both compounds were found to be stable at pH 4 and at 4 degrees C. However, at pH 5.5 they lost almost 10% of the initial activity during 5days of storage at 4 degrees C. The fastest decay of ALA and MAL was seen at pH 7.4 and at 37 degrees C, and followed first order kinetics. At pH 7.4 and at 4 degrees C MAL lost its PpIX producing ability more slowly than at 37 degrees C. Our work shows that solutions should be prepared immediately before use and stored at low temperatures. The pH of stock solutions should not exceed 5.

[1]  S. Ferrone,et al.  Characterization of WiDr: A human colon carcinoma cell line , 1979, In Vitro.

[2]  C. Perotti,et al.  A method for separating ALA from ALA derivatives using ionic exchange extraction. , 2004, Journal of photochemistry and photobiology. B, Biology.

[3]  G. Oremek,et al.  Enhancement of photodynamic therapy by use of aminolevulinic acid/glycolic acid drug mixture. , 2004, Journal of experimental therapeutics & oncology.

[4]  Petras Juzenas,et al.  Topical Application of 5-Aminolevulinic Acid and its Methylester, Hexylester and Octylester Derivatives: Considerations for Dosimetry in Mouse Skin Model¶ , 2002, Photochemistry and photobiology.

[5]  G Hüttmann,et al.  Chemical instability of 5-aminolevulinic acid used in the fluorescence diagnosis of bladder tumours. , 1996, Journal of photochemistry and photobiology. B, Biology.

[6]  G. C. Ferreira,et al.  Supraphysiological concentrations of 5-aminolevulinic acid dimerize in solution to produce superoxide radical anions via a protonated dihydropyrazine intermediate. , 2005, Archives of biochemistry and biophysics.

[7]  G. Andrews,et al.  Stability of 5-aminolevulinic acid in novel non-aqueous gel and patch-type systems intended for topical application. , 2005, Journal of pharmaceutical sciences.

[8]  A. Batlle,et al.  Rational design of 5-aminolevulinic acid derivatives aimed at improving photodynamic therapy. , 2002, Current medicinal chemistry. Anti-cancer agents.

[9]  F. Denizot,et al.  Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. , 1986, Journal of immunological methods.

[10]  B. Gander,et al.  Degradation mechanism and stability of 5-aminolevulinic acid. , 2000, Journal of pharmaceutical sciences.

[11]  Joris Kloek,et al.  Prodrugs of 5‐Aminolevullinic Acid for Photodynamic Therapy , 1996, Photochemistry and photobiology.

[12]  C. Valenta,et al.  Influence of 6-ketocholestanol on skin permeation of 5-aminolevulinic acid and evaluation of chemical stability. , 2004, Journal of pharmaceutical sciences.

[13]  V. Kosma,et al.  The effect of photodynamic therapy on rat urinary bladder with orthotopic urothelial carcinoma , 2003, BJU international.

[14]  A. MacRobert,et al.  Distribution of 5-aminolevulinic acid derivatives and induced porphyrin kinetics in mice tissues , 2006, Cancer Chemotherapy and Pharmacology.

[15]  J. Moan,et al.  Formation of protoporphyrin IX from carboxylic- and amino-derivatives of 5-aminolevulinic acid. , 2005, Photodiagnosis and photodynamic therapy.

[16]  R. Grouls,et al.  Development of a Stable Solution of 5-Aminolaevulinic Acid for Intracutaneous Injection in Photodynamic Therapy , 2002, Lasers in Medical Science.

[17]  S. Eksborg,et al.  Stability of 5-aminolevulinic acid in aqueous solution. , 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[18]  J. Moan,et al.  Production of protoporphyrin IX from 5-aminolevulinic acid and two of its esters in cells in vitro and tissues in vivo. , 2002, Cellular and Molecular Biology.

[19]  G. Andrews,et al.  Analysis of pyrazine 2,5-dipropionic acid in 5-aminolevulinic acid-loaded urological and topical delivery vehicles: methodology and assay validation. , 2005, Journal of pharmaceutical and biomedical analysis.

[20]  Qian Peng,et al.  The stability of 5-aminolevulinic acid in solution. , 2002, Journal of photochemistry and photobiology. B, Biology.